SCHEMBL9067770

SCHEMBL9067770

O=C(O)c1ccc(NC(=O)c2cccc(C(=O)Nc3ccc(C(=O)O)cc3)c2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 7/20 1.00
▸ MEN1 O00255 6/20 1.00
▸ L3MBTL1 Q9Y468 2/20 0.76
▸ PKM P14618 1/20 0.76
▸ FFAR1 O14842 1/20 0.71
▸ TP53 P04637 1/20 0.68
▸ HPSE Q9Y251 1/20 0.68
▸ HDAC1 Q13547 1/20 0.66
▸ HDAC2 Q92769 1/20 0.66
▸ HDAC8 Q9BY41 1/20 0.66
▸ HDAC6 Q9UBN7 1/20 0.66
▸ MITF O75030 1/20 0.62
▸ POLB P06746 2/20 0.61
▸ NPC1 O15118 1/20 0.61
▸ RAB9A P51151 1/20 0.61
▸ KDM4E B2RXH2 1/20 0.61
▸ PTPN1 P18031 2/20 0.59
▸ KCNK3 O14649 1/20 0.58
▸ KCNK9 Q9NPC2 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2058359 0.98 KMT2A (0.96) KMT2AMEN1L3MBTL1PKMFFAR1
SCHEMBL28595821 0.92 KMT2A (0.84) KMT2AMEN1L3MBTL1PKMFFAR1
SCHEMBL6242641 0.90 MEN1 (0.81) KMT2AMEN1L3MBTL1PKMFFAR1
SCHEMBL11474161 0.89 KMT2A (0.79) KMT2AMEN1L3MBTL1PKMFFAR1
SCHEMBL14715851 0.88 KMT2A (0.79) KMT2AMEN1L3MBTL1PKMTP53
SCHEMBL3659600 0.88 FFAR1 (0.89) KMT2AMEN1FFAR1HPSEHDAC2
SCHEMBL6866138 0.88 KMT2A (0.78) KMT2AMEN1L3MBTL1PKMFFAR1
SCHEMBL13802448 0.88 MEN1 (0.78) KMT2AMEN1L3MBTL1PKMFFAR1
SCHEMBL7822889 0.88 MEN1 (0.78) KMT2AMEN1L3MBTL1PKMFFAR1
SCHEMBL6802691 0.88 KMT2A (0.78) KMT2AMEN1L3MBTL1PKMFFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100081661-A1 HEME OXYGENASE INHIBITORS, SCREENING METHODS FOR HEME OXYGENASE INHIBITORS AND METHODS OF USE OF HEME OXYGENASE INHIBITORS FOR ANTIMICROBIAL THERAPY UNIVERSITY OF MARYLAND, BALTIMORE (US) 2010-04-01 — — US disclosed
US-20100081661-A1 HEME OXYGENASE INHIBITORS, SCREENING METHODS FOR HEME OXYGENASE INHIBITORS AND METHODS OF USE OF HEME OXYGENASE INHIBITORS FOR ANTIMICROBIAL THERAPY UNIVERSITY OF MARYLAND, BALTIMORE (US) 2010-04-01 — — US disclosed
US-5493022-A Brightener and light stabilizer salts SANDOZ LTD. (CH) 1996-02-20 — — US disclosed
EP-0451228-B1 BRIGHTENING AND LIGHT-STABILIZING SALTS SANDOZ AG (DE) 1994-12-28 — — EP disclosed
US-5316553-A Dyestuffs for the dyeing of synthetic polyamides SANDOZ LTD. (CH) 1994-05-31 — — US disclosed
EP-0451228-A1 BRIGHTENING AND LIGHT-STABILIZING SALTS. SANDOZ AG (DE) 1991-10-16 — — EP disclosed
US-5037448-A Processes for the mass dyeing of synthetic polyamides SANDOZ LTD. (CH) 1991-08-06 — — US disclosed
WO-1991004987-A1 BRIGHTENING AND LIGHT-STABILIZING SALTS SANDOZ LTD. (CH) 1991-04-18 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100081661-A1 HEME OXYGENASE INHIBITORS, SCREENING METHODS FOR HEME OXYGENASE INHIBITORS AND METHODS OF USE OF HEME OXYGENASE INHIBITORS FOR ANTIMICROBIAL THERAPY HMOX1, HMOX2, PPOX KMT2A 3310/4885MEN1 4396/4885L3MBTL1 2420/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback